Stoke Therapeutics(STOK)
Focus: Stoke Therapeutics is a public biotech company focused on antisense oligonucleotide (ASO) medicines for gene therapy applications, headquartered in Bedford, MA. The company is early-stage with minimal commercial revenue and a pipeline concentrated in rare neurological and genetic disorders.
Profile data last refreshed 16m ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
10-14 this month
Cooling — net -14 jobs in 30d
4 added, 18 removed. Slower than typical.
Should You Work at Stoke Therapeutics?
AI assessmentStoke offers exposure to cutting-edge ASO science and rare disease focus, but significant cash burn and lack of commercial traction create meaningful career stability risk for all-but-equity-motivated candidates.
Why Work Here
- Leading ASO platform in rare genetic diseases (Dravet Syndrome Phase 3 program zorevunersen shows clinical validation)
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$37M
Pipeline & Clinical Trials
Experimental: Device Intervention
Spinal Cord InjuriesClinical Trials (1)
NCT05615766Assessment of a Robotic Exoskeleton for Upper Limb Rehabilitation
N/AHelp build intelligence for Stoke Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.